nodes	percent_of_prediction	percent_of_DWPC	metapath
Phendimetrazine—ADRA1B—vas deferens—prostate cancer	0.197	0.798	CbGeAlD
Phendimetrazine—ADRA1B—renal system—prostate cancer	0.012	0.0486	CbGeAlD
Phendimetrazine—Blood pressure increased—Estrone—prostate cancer	0.0118	0.0233	CcSEcCtD
Phendimetrazine—Blood pressure increased—Estradiol valerate/Dienogest—prostate cancer	0.0103	0.0204	CcSEcCtD
Phendimetrazine—ADRA1A—prostate gland—prostate cancer	0.00989	0.0401	CbGeAlD
Phendimetrazine—Stomach ache—Mitoxantrone—prostate cancer	0.00953	0.0189	CcSEcCtD
Phendimetrazine—ADRA1A—epithelium—prostate cancer	0.00727	0.0294	CbGeAlD
Phendimetrazine—Pollakiuria—Abiraterone—prostate cancer	0.00693	0.0138	CcSEcCtD
Phendimetrazine—ADRA1A—renal system—prostate cancer	0.00674	0.0273	CbGeAlD
Phendimetrazine—Blood pressure increased—Ethinyl Estradiol—prostate cancer	0.00666	0.0132	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Cabazitaxel—prostate cancer	0.00609	0.0121	CcSEcCtD
Phendimetrazine—Sweating—Nilutamide—prostate cancer	0.00586	0.0116	CcSEcCtD
Phendimetrazine—SLC6A3—testis—prostate cancer	0.00581	0.0235	CbGeAlD
Phendimetrazine—Flushing—Estramustine—prostate cancer	0.00574	0.0114	CcSEcCtD
Phendimetrazine—Dysuria—Degarelix—prostate cancer	0.00572	0.0114	CcSEcCtD
Phendimetrazine—Pollakiuria—Degarelix—prostate cancer	0.00565	0.0112	CcSEcCtD
Phendimetrazine—Blood pressure increased—Conjugated Estrogens—prostate cancer	0.00543	0.0108	CcSEcCtD
Phendimetrazine—Dysuria—Cabazitaxel—prostate cancer	0.00539	0.0107	CcSEcCtD
Phendimetrazine—Pollakiuria—Cabazitaxel—prostate cancer	0.00533	0.0106	CcSEcCtD
Phendimetrazine—SLC6A2—testis—prostate cancer	0.00469	0.019	CbGeAlD
Phendimetrazine—Dysuria—Bicalutamide—prostate cancer	0.00462	0.00918	CcSEcCtD
Phendimetrazine—Pollakiuria—Bicalutamide—prostate cancer	0.00457	0.00907	CcSEcCtD
Phendimetrazine—Blood pressure increased—Estradiol—prostate cancer	0.00435	0.00863	CcSEcCtD
Phendimetrazine—Flushing—Cabazitaxel—prostate cancer	0.00428	0.0085	CcSEcCtD
Phendimetrazine—Sweating—Bicalutamide—prostate cancer	0.00423	0.00839	CcSEcCtD
Phendimetrazine—Anorexia—Estramustine—prostate cancer	0.00418	0.00831	CcSEcCtD
Phendimetrazine—Vision blurred—Degarelix—prostate cancer	0.00402	0.00798	CcSEcCtD
Phendimetrazine—Insomnia—Estramustine—prostate cancer	0.00397	0.00789	CcSEcCtD
Phendimetrazine—Palpitations—Estradiol valerate/Dienogest—prostate cancer	0.00396	0.00787	CcSEcCtD
Phendimetrazine—Dysuria—Ethinyl Estradiol—prostate cancer	0.00391	0.00776	CcSEcCtD
Phendimetrazine—Psychotic disorder—Goserelin—prostate cancer	0.00389	0.00772	CcSEcCtD
Phendimetrazine—Pollakiuria—Ethinyl Estradiol—prostate cancer	0.00386	0.00767	CcSEcCtD
Phendimetrazine—Insomnia—Abiraterone—prostate cancer	0.00386	0.00766	CcSEcCtD
Phendimetrazine—Decreased appetite—Estramustine—prostate cancer	0.00382	0.00758	CcSEcCtD
Phendimetrazine—Palpitations—Degarelix—prostate cancer	0.00377	0.00748	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Nilutamide—prostate cancer	0.00377	0.00748	CcSEcCtD
Phendimetrazine—Anorexia—Nilutamide—prostate cancer	0.00371	0.00737	CcSEcCtD
Phendimetrazine—Anorexia—Flutamide—prostate cancer	0.0037	0.00734	CcSEcCtD
Phendimetrazine—Constipation—Abiraterone—prostate cancer	0.00365	0.00724	CcSEcCtD
Phendimetrazine—Insomnia—Nilutamide—prostate cancer	0.00352	0.007	CcSEcCtD
Phendimetrazine—Insomnia—Flutamide—prostate cancer	0.00351	0.00697	CcSEcCtD
Phendimetrazine—SLC6A2—lymph node—prostate cancer	0.0034	0.0138	CbGeAlD
Phendimetrazine—Decreased appetite—Nilutamide—prostate cancer	0.00339	0.00673	CcSEcCtD
Phendimetrazine—Decreased appetite—Flutamide—prostate cancer	0.00337	0.0067	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Degarelix—prostate cancer	0.00336	0.00668	CcSEcCtD
Phendimetrazine—Constipation—Nilutamide—prostate cancer	0.00333	0.00662	CcSEcCtD
Phendimetrazine—Constipation—Flutamide—prostate cancer	0.00332	0.00659	CcSEcCtD
Phendimetrazine—Abdominal pain—Estrone—prostate cancer	0.00332	0.00658	CcSEcCtD
Phendimetrazine—Dysuria—Goserelin—prostate cancer	0.00322	0.00639	CcSEcCtD
Phendimetrazine—Tachycardia—Cabazitaxel—prostate cancer	0.0032	0.00635	CcSEcCtD
Phendimetrazine—Dysuria—Conjugated Estrogens—prostate cancer	0.00319	0.00633	CcSEcCtD
Phendimetrazine—Pollakiuria—Goserelin—prostate cancer	0.00318	0.00631	CcSEcCtD
Phendimetrazine—Insomnia—Degarelix—prostate cancer	0.00315	0.00625	CcSEcCtD
Phendimetrazine—Anorexia—Cabazitaxel—prostate cancer	0.00312	0.00621	CcSEcCtD
Phendimetrazine—Abdominal pain—Nilutamide—prostate cancer	0.00308	0.00612	CcSEcCtD
Phendimetrazine—Decreased appetite—Degarelix—prostate cancer	0.00302	0.00601	CcSEcCtD
Phendimetrazine—Diarrhoea—Estramustine—prostate cancer	0.003	0.00597	CcSEcCtD
Phendimetrazine—Constipation—Degarelix—prostate cancer	0.00298	0.00591	CcSEcCtD
Phendimetrazine—Sweating—Goserelin—prostate cancer	0.00294	0.00584	CcSEcCtD
Phendimetrazine—Diarrhoea—Abiraterone—prostate cancer	0.00292	0.00579	CcSEcCtD
Phendimetrazine—Abdominal pain—Estradiol valerate/Dienogest—prostate cancer	0.00289	0.00575	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Estradiol—prostate cancer	0.00288	0.00572	CcSEcCtD
Phendimetrazine—Tranylcypromine—CYP2A6—prostate cancer	0.00288	0.263	CrCbGaD
Phendimetrazine—Decreased appetite—Cabazitaxel—prostate cancer	0.00285	0.00566	CcSEcCtD
Phendimetrazine—Constipation—Cabazitaxel—prostate cancer	0.0028	0.00557	CcSEcCtD
Phendimetrazine—Blood pressure increased—Docetaxel—prostate cancer	0.0028	0.00556	CcSEcCtD
Phendimetrazine—Dizziness—Estrone—prostate cancer	0.00277	0.00551	CcSEcCtD
Phendimetrazine—Abdominal pain—Degarelix—prostate cancer	0.00275	0.00546	CcSEcCtD
Phendimetrazine—Headache—Estramustine—prostate cancer	0.00275	0.00546	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Bicalutamide—prostate cancer	0.00272	0.0054	CcSEcCtD
Phendimetrazine—Phensuximide—CYP2C19—prostate cancer	0.00271	0.248	CrCbGaD
Phendimetrazine—Blood pressure increased—Capecitabine—prostate cancer	0.00271	0.00538	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Mitoxantrone—prostate cancer	0.00269	0.00533	CcSEcCtD
Phendimetrazine—Anorexia—Bicalutamide—prostate cancer	0.00268	0.00532	CcSEcCtD
Phendimetrazine—Diarrhoea—Nilutamide—prostate cancer	0.00267	0.00529	CcSEcCtD
Phendimetrazine—Diarrhoea—Flutamide—prostate cancer	0.00265	0.00527	CcSEcCtD
Phendimetrazine—Headache—Estrone—prostate cancer	0.00263	0.00522	CcSEcCtD
Phendimetrazine—Nausea—Estramustine—prostate cancer	0.00261	0.00518	CcSEcCtD
Phendimetrazine—Abdominal pain—Cabazitaxel—prostate cancer	0.00259	0.00515	CcSEcCtD
Phendimetrazine—Dizziness—Nilutamide—prostate cancer	0.00258	0.00512	CcSEcCtD
Phendimetrazine—Dizziness—Flutamide—prostate cancer	0.00256	0.00509	CcSEcCtD
Phendimetrazine—Insomnia—Bicalutamide—prostate cancer	0.00254	0.00505	CcSEcCtD
Phendimetrazine—Pollakiuria—Estradiol—prostate cancer	0.00252	0.005	CcSEcCtD
Phendimetrazine—Nausea—Estrone—prostate cancer	0.00249	0.00495	CcSEcCtD
Phendimetrazine—Decreased appetite—Bicalutamide—prostate cancer	0.00244	0.00485	CcSEcCtD
Phendimetrazine—Headache—Nilutamide—prostate cancer	0.00244	0.00485	CcSEcCtD
Phendimetrazine—Headache—Flutamide—prostate cancer	0.00243	0.00482	CcSEcCtD
Phendimetrazine—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00242	0.00481	CcSEcCtD
Phendimetrazine—Constipation—Bicalutamide—prostate cancer	0.0024	0.00478	CcSEcCtD
Phendimetrazine—Diarrhoea—Degarelix—prostate cancer	0.00238	0.00473	CcSEcCtD
Phendimetrazine—Nausea—Nilutamide—prostate cancer	0.00231	0.0046	CcSEcCtD
Phendimetrazine—Nausea—Flutamide—prostate cancer	0.0023	0.00457	CcSEcCtD
Phendimetrazine—Dizziness—Degarelix—prostate cancer	0.0023	0.00457	CcSEcCtD
Phendimetrazine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00229	0.00455	CcSEcCtD
Phendimetrazine—Vision blurred—Goserelin—prostate cancer	0.00226	0.00449	CcSEcCtD
Phendimetrazine—Diarrhoea—Cabazitaxel—prostate cancer	0.00224	0.00445	CcSEcCtD
Phendimetrazine—Vision blurred—Conjugated Estrogens—prostate cancer	0.00224	0.00444	CcSEcCtD
Phendimetrazine—Abdominal pain—Bicalutamide—prostate cancer	0.00222	0.00441	CcSEcCtD
Phendimetrazine—Headache—Degarelix—prostate cancer	0.00218	0.00433	CcSEcCtD
Phendimetrazine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00217	0.00432	CcSEcCtD
Phendimetrazine—Sweating—Mitoxantrone—prostate cancer	0.00217	0.00431	CcSEcCtD
Phendimetrazine—Dizziness—Cabazitaxel—prostate cancer	0.00217	0.00431	CcSEcCtD
Phendimetrazine—Palpitations—Goserelin—prostate cancer	0.00212	0.00421	CcSEcCtD
Phendimetrazine—Palpitations—Conjugated Estrogens—prostate cancer	0.0021	0.00417	CcSEcCtD
Phendimetrazine—Nausea—Degarelix—prostate cancer	0.00207	0.0041	CcSEcCtD
Phendimetrazine—Headache—Cabazitaxel—prostate cancer	0.00205	0.00408	CcSEcCtD
Phendimetrazine—Tranylcypromine—CYP2E1—prostate cancer	0.00205	0.187	CrCbGaD
Phendimetrazine—Constipation—Ethinyl Estradiol—prostate cancer	0.00203	0.00404	CcSEcCtD
Phendimetrazine—Tranylcypromine—CYP2C19—prostate cancer	0.00203	0.185	CrCbGaD
Phendimetrazine—Flushing—Estradiol—prostate cancer	0.00203	0.00402	CcSEcCtD
Phendimetrazine—Nausea—Cabazitaxel—prostate cancer	0.00195	0.00387	CcSEcCtD
Phendimetrazine—Diarrhoea—Bicalutamide—prostate cancer	0.00192	0.00382	CcSEcCtD
Phendimetrazine—Tachycardia—Goserelin—prostate cancer	0.00191	0.00379	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Goserelin—prostate cancer	0.00189	0.00376	CcSEcCtD
Phendimetrazine—Tachycardia—Conjugated Estrogens—prostate cancer	0.00189	0.00376	CcSEcCtD
Phendimetrazine—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.00188	0.00373	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.00187	0.00372	CcSEcCtD
Phendimetrazine—Anorexia—Goserelin—prostate cancer	0.00186	0.0037	CcSEcCtD
Phendimetrazine—Dizziness—Bicalutamide—prostate cancer	0.00186	0.00369	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Docetaxel—prostate cancer	0.00186	0.00369	CcSEcCtD
Phendimetrazine—Anorexia—Conjugated Estrogens—prostate cancer	0.00185	0.00367	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Capecitabine—prostate cancer	0.0018	0.00357	CcSEcCtD
Phendimetrazine—Tremor—Estradiol—prostate cancer	0.00178	0.00354	CcSEcCtD
Phendimetrazine—Insomnia—Goserelin—prostate cancer	0.00177	0.00351	CcSEcCtD
Phendimetrazine—Headache—Bicalutamide—prostate cancer	0.00176	0.0035	CcSEcCtD
Phendimetrazine—Insomnia—Conjugated Estrogens—prostate cancer	0.00175	0.00348	CcSEcCtD
Phendimetrazine—Agitation—Estradiol—prostate cancer	0.00175	0.00347	CcSEcCtD
Phendimetrazine—Psychotic disorder—Prednisone—prostate cancer	0.00171	0.0034	CcSEcCtD
Phendimetrazine—Decreased appetite—Goserelin—prostate cancer	0.0017	0.00338	CcSEcCtD
Phendimetrazine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.00168	0.00335	CcSEcCtD
Phendimetrazine—Palpitations—Estradiol—prostate cancer	0.00168	0.00333	CcSEcCtD
Phendimetrazine—Constipation—Goserelin—prostate cancer	0.00167	0.00332	CcSEcCtD
Phendimetrazine—Nausea—Bicalutamide—prostate cancer	0.00167	0.00332	CcSEcCtD
Phendimetrazine—Vision blurred—Mitoxantrone—prostate cancer	0.00167	0.00331	CcSEcCtD
Phendimetrazine—Constipation—Conjugated Estrogens—prostate cancer	0.00166	0.00329	CcSEcCtD
Phendimetrazine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00163	0.00323	CcSEcCtD
Phendimetrazine—Dysuria—Capecitabine—prostate cancer	0.00159	0.00316	CcSEcCtD
Phendimetrazine—Dizziness—Ethinyl Estradiol—prostate cancer	0.00157	0.00312	CcSEcCtD
Phendimetrazine—Flushing—Etoposide—prostate cancer	0.00157	0.00312	CcSEcCtD
Phendimetrazine—Abdominal pain—Goserelin—prostate cancer	0.00155	0.00307	CcSEcCtD
Phendimetrazine—Abdominal pain—Conjugated Estrogens—prostate cancer	0.00153	0.00304	CcSEcCtD
Phendimetrazine—Tachycardia—Estradiol—prostate cancer	0.00151	0.00301	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Estradiol—prostate cancer	0.0015	0.00298	CcSEcCtD
Phendimetrazine—Headache—Ethinyl Estradiol—prostate cancer	0.00149	0.00296	CcSEcCtD
Phendimetrazine—Nausea—Ethinyl Estradiol—prostate cancer	0.00141	0.0028	CcSEcCtD
Phendimetrazine—Tachycardia—Mitoxantrone—prostate cancer	0.00141	0.0028	CcSEcCtD
Phendimetrazine—Insomnia—Estradiol—prostate cancer	0.0014	0.00279	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.0014	0.00277	CcSEcCtD
Phendimetrazine—Anorexia—Mitoxantrone—prostate cancer	0.00138	0.00274	CcSEcCtD
Phendimetrazine—Decreased appetite—Estradiol—prostate cancer	0.00135	0.00268	CcSEcCtD
Phendimetrazine—Diarrhoea—Goserelin—prostate cancer	0.00134	0.00266	CcSEcCtD
Phendimetrazine—Constipation—Estradiol—prostate cancer	0.00133	0.00263	CcSEcCtD
Phendimetrazine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00133	0.00263	CcSEcCtD
Phendimetrazine—Flushing—Docetaxel—prostate cancer	0.0013	0.00259	CcSEcCtD
Phendimetrazine—Dizziness—Goserelin—prostate cancer	0.00129	0.00257	CcSEcCtD
Phendimetrazine—Tranylcypromine—CYP3A4—prostate cancer	0.00129	0.118	CrCbGaD
Phendimetrazine—Dizziness—Conjugated Estrogens—prostate cancer	0.00128	0.00254	CcSEcCtD
Phendimetrazine—Flushing—Capecitabine—prostate cancer	0.00126	0.00251	CcSEcCtD
Phendimetrazine—Decreased appetite—Mitoxantrone—prostate cancer	0.00126	0.00249	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Epirubicin—prostate cancer	0.00125	0.00249	CcSEcCtD
Phendimetrazine—Constipation—Mitoxantrone—prostate cancer	0.00124	0.00245	CcSEcCtD
Phendimetrazine—Abdominal pain—Estradiol—prostate cancer	0.00123	0.00243	CcSEcCtD
Phendimetrazine—Headache—Goserelin—prostate cancer	0.00123	0.00243	CcSEcCtD
Phendimetrazine—Headache—Conjugated Estrogens—prostate cancer	0.00121	0.00241	CcSEcCtD
Phendimetrazine—Tachycardia—Etoposide—prostate cancer	0.00117	0.00233	CcSEcCtD
Phendimetrazine—Nausea—Goserelin—prostate cancer	0.00116	0.00231	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Etoposide—prostate cancer	0.00116	0.00231	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Doxorubicin—prostate cancer	0.00116	0.0023	CcSEcCtD
Phendimetrazine—Nausea—Conjugated Estrogens—prostate cancer	0.00115	0.00229	CcSEcCtD
Phendimetrazine—Anorexia—Etoposide—prostate cancer	0.00115	0.00228	CcSEcCtD
Phendimetrazine—Abdominal pain—Mitoxantrone—prostate cancer	0.00114	0.00227	CcSEcCtD
Phendimetrazine—Flushing—Prednisone—prostate cancer	0.00113	0.00223	CcSEcCtD
Phendimetrazine—Vision blurred—Capecitabine—prostate cancer	0.00112	0.00222	CcSEcCtD
Phendimetrazine—Tremor—Capecitabine—prostate cancer	0.00111	0.0022	CcSEcCtD
Phendimetrazine—Dysuria—Epirubicin—prostate cancer	0.00111	0.0022	CcSEcCtD
Phendimetrazine—Pollakiuria—Epirubicin—prostate cancer	0.00109	0.00217	CcSEcCtD
Phendimetrazine—Palpitations—Docetaxel—prostate cancer	0.00108	0.00215	CcSEcCtD
Phendimetrazine—Diarrhoea—Estradiol—prostate cancer	0.00106	0.00211	CcSEcCtD
Phendimetrazine—Palpitations—Capecitabine—prostate cancer	0.00105	0.00208	CcSEcCtD
Phendimetrazine—Decreased appetite—Etoposide—prostate cancer	0.00104	0.00208	CcSEcCtD
Phendimetrazine—Constipation—Etoposide—prostate cancer	0.00103	0.00204	CcSEcCtD
Phendimetrazine—Dizziness—Estradiol—prostate cancer	0.00103	0.00204	CcSEcCtD
Phendimetrazine—Dysuria—Doxorubicin—prostate cancer	0.00103	0.00204	CcSEcCtD
Phendimetrazine—Sweating—Epirubicin—prostate cancer	0.00101	0.00201	CcSEcCtD
Phendimetrazine—Pollakiuria—Doxorubicin—prostate cancer	0.00101	0.00201	CcSEcCtD
Phendimetrazine—Vision blurred—Prednisone—prostate cancer	0.000995	0.00198	CcSEcCtD
Phendimetrazine—Diarrhoea—Mitoxantrone—prostate cancer	0.000989	0.00196	CcSEcCtD
Phendimetrazine—Tachycardia—Docetaxel—prostate cancer	0.000975	0.00194	CcSEcCtD
Phendimetrazine—Headache—Estradiol—prostate cancer	0.000972	0.00193	CcSEcCtD
Phendimetrazine—Agitation—Prednisone—prostate cancer	0.00097	0.00193	CcSEcCtD
Phendimetrazine—Anorexia—Docetaxel—prostate cancer	0.000952	0.00189	CcSEcCtD
Phendimetrazine—Abdominal pain—Etoposide—prostate cancer	0.00095	0.00189	CcSEcCtD
Phendimetrazine—Tachycardia—Capecitabine—prostate cancer	0.000944	0.00187	CcSEcCtD
Phendimetrazine—Sweating—Doxorubicin—prostate cancer	0.000937	0.00186	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Capecitabine—prostate cancer	0.000935	0.00186	CcSEcCtD
Phendimetrazine—Anorexia—Capecitabine—prostate cancer	0.000922	0.00183	CcSEcCtD
Phendimetrazine—Nausea—Estradiol—prostate cancer	0.000921	0.00183	CcSEcCtD
Phendimetrazine—Headache—Mitoxantrone—prostate cancer	0.000905	0.0018	CcSEcCtD
Phendimetrazine—Insomnia—Docetaxel—prostate cancer	0.000903	0.00179	CcSEcCtD
Phendimetrazine—Flushing—Epirubicin—prostate cancer	0.00088	0.00175	CcSEcCtD
Phendimetrazine—Insomnia—Capecitabine—prostate cancer	0.000875	0.00174	CcSEcCtD
Phendimetrazine—Decreased appetite—Docetaxel—prostate cancer	0.000868	0.00172	CcSEcCtD
Phendimetrazine—Nausea—Mitoxantrone—prostate cancer	0.000858	0.0017	CcSEcCtD
Phendimetrazine—Constipation—Docetaxel—prostate cancer	0.000854	0.0017	CcSEcCtD
Phendimetrazine—Tachycardia—Prednisone—prostate cancer	0.000841	0.00167	CcSEcCtD
Phendimetrazine—Decreased appetite—Capecitabine—prostate cancer	0.000841	0.00167	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Prednisone—prostate cancer	0.000833	0.00165	CcSEcCtD
Phendimetrazine—Constipation—Capecitabine—prostate cancer	0.000827	0.00164	CcSEcCtD
Phendimetrazine—Diarrhoea—Etoposide—prostate cancer	0.000822	0.00163	CcSEcCtD
Phendimetrazine—Anorexia—Prednisone—prostate cancer	0.000821	0.00163	CcSEcCtD
Phendimetrazine—Flushing—Doxorubicin—prostate cancer	0.000814	0.00162	CcSEcCtD
Phendimetrazine—Dizziness—Etoposide—prostate cancer	0.000795	0.00158	CcSEcCtD
Phendimetrazine—Abdominal pain—Docetaxel—prostate cancer	0.00079	0.00157	CcSEcCtD
Phendimetrazine—Insomnia—Prednisone—prostate cancer	0.000779	0.00155	CcSEcCtD
Phendimetrazine—Vision blurred—Epirubicin—prostate cancer	0.000778	0.00155	CcSEcCtD
Phendimetrazine—Abdominal pain—Capecitabine—prostate cancer	0.000765	0.00152	CcSEcCtD
Phendimetrazine—Agitation—Epirubicin—prostate cancer	0.000759	0.00151	CcSEcCtD
Phendimetrazine—Headache—Etoposide—prostate cancer	0.000753	0.0015	CcSEcCtD
Phendimetrazine—Decreased appetite—Prednisone—prostate cancer	0.000749	0.00149	CcSEcCtD
Phendimetrazine—Constipation—Prednisone—prostate cancer	0.000737	0.00146	CcSEcCtD
Phendimetrazine—Palpitations—Epirubicin—prostate cancer	0.00073	0.00145	CcSEcCtD
Phendimetrazine—Vision blurred—Doxorubicin—prostate cancer	0.00072	0.00143	CcSEcCtD
Phendimetrazine—Nausea—Etoposide—prostate cancer	0.000714	0.00142	CcSEcCtD
Phendimetrazine—Agitation—Doxorubicin—prostate cancer	0.000702	0.00139	CcSEcCtD
Phendimetrazine—Diarrhoea—Docetaxel—prostate cancer	0.000683	0.00136	CcSEcCtD
Phendimetrazine—Abdominal pain—Prednisone—prostate cancer	0.000681	0.00135	CcSEcCtD
Phendimetrazine—Palpitations—Doxorubicin—prostate cancer	0.000675	0.00134	CcSEcCtD
Phendimetrazine—Diarrhoea—Capecitabine—prostate cancer	0.000662	0.00131	CcSEcCtD
Phendimetrazine—Dizziness—Docetaxel—prostate cancer	0.000661	0.00131	CcSEcCtD
Phendimetrazine—Tachycardia—Epirubicin—prostate cancer	0.000658	0.00131	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Epirubicin—prostate cancer	0.000651	0.00129	CcSEcCtD
Phendimetrazine—Anorexia—Epirubicin—prostate cancer	0.000642	0.00128	CcSEcCtD
Phendimetrazine—Dizziness—Capecitabine—prostate cancer	0.00064	0.00127	CcSEcCtD
Phendimetrazine—Headache—Docetaxel—prostate cancer	0.000626	0.00124	CcSEcCtD
Phendimetrazine—Insomnia—Epirubicin—prostate cancer	0.000609	0.00121	CcSEcCtD
Phendimetrazine—Tachycardia—Doxorubicin—prostate cancer	0.000608	0.00121	CcSEcCtD
Phendimetrazine—Headache—Capecitabine—prostate cancer	0.000606	0.0012	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000603	0.0012	CcSEcCtD
Phendimetrazine—Anorexia—Doxorubicin—prostate cancer	0.000594	0.00118	CcSEcCtD
Phendimetrazine—Nausea—Docetaxel—prostate cancer	0.000593	0.00118	CcSEcCtD
Phendimetrazine—Diarrhoea—Prednisone—prostate cancer	0.000589	0.00117	CcSEcCtD
Phendimetrazine—Decreased appetite—Epirubicin—prostate cancer	0.000586	0.00116	CcSEcCtD
Phendimetrazine—Constipation—Epirubicin—prostate cancer	0.000576	0.00114	CcSEcCtD
Phendimetrazine—Nausea—Capecitabine—prostate cancer	0.000574	0.00114	CcSEcCtD
Phendimetrazine—Dizziness—Prednisone—prostate cancer	0.00057	0.00113	CcSEcCtD
Phendimetrazine—Insomnia—Doxorubicin—prostate cancer	0.000564	0.00112	CcSEcCtD
Phendimetrazine—Decreased appetite—Doxorubicin—prostate cancer	0.000542	0.00108	CcSEcCtD
Phendimetrazine—Headache—Prednisone—prostate cancer	0.00054	0.00107	CcSEcCtD
Phendimetrazine—Constipation—Doxorubicin—prostate cancer	0.000533	0.00106	CcSEcCtD
Phendimetrazine—Abdominal pain—Epirubicin—prostate cancer	0.000533	0.00106	CcSEcCtD
Phendimetrazine—Nausea—Prednisone—prostate cancer	0.000512	0.00102	CcSEcCtD
Phendimetrazine—Abdominal pain—Doxorubicin—prostate cancer	0.000493	0.000979	CcSEcCtD
Phendimetrazine—Diarrhoea—Epirubicin—prostate cancer	0.000461	0.000915	CcSEcCtD
Phendimetrazine—Dizziness—Epirubicin—prostate cancer	0.000446	0.000885	CcSEcCtD
Phendimetrazine—Diarrhoea—Doxorubicin—prostate cancer	0.000427	0.000847	CcSEcCtD
Phendimetrazine—Headache—Epirubicin—prostate cancer	0.000422	0.000838	CcSEcCtD
Phendimetrazine—Dizziness—Doxorubicin—prostate cancer	0.000412	0.000819	CcSEcCtD
Phendimetrazine—Nausea—Epirubicin—prostate cancer	0.0004	0.000795	CcSEcCtD
Phendimetrazine—Headache—Doxorubicin—prostate cancer	0.000391	0.000776	CcSEcCtD
Phendimetrazine—Nausea—Doxorubicin—prostate cancer	0.00037	0.000735	CcSEcCtD
Phendimetrazine—ADRA1A—Signaling by GPCR—PRKACB—prostate cancer	9.31e-05	0.00039	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PRKCQ—prostate cancer	9.25e-05	0.000388	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CALCA—prostate cancer	9.22e-05	0.000386	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CXCL12—prostate cancer	9.21e-05	0.000386	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	9.1e-05	0.000381	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PPP3CA—prostate cancer	9.07e-05	0.00038	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CXCL12—prostate cancer	9.01e-05	0.000377	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NRP1—prostate cancer	8.98e-05	0.000376	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ANXA1—prostate cancer	8.94e-05	0.000375	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PENK—prostate cancer	8.72e-05	0.000365	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—ADRB2—prostate cancer	8.7e-05	0.000365	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	8.67e-05	0.000363	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	8.56e-05	0.000359	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—VAV3—prostate cancer	8.48e-05	0.000355	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PRKCQ—prostate cancer	8.4e-05	0.000352	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CALCA—prostate cancer	8.37e-05	0.000351	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	8.36e-05	0.00035	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VIP—prostate cancer	8.35e-05	0.00035	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GNRH1—prostate cancer	8.35e-05	0.00035	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	8.32e-05	0.000349	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GHR—prostate cancer	8.32e-05	0.000349	CbGpPWpGaD
Phendimetrazine—ADRA1A—G alpha (q) signalling events—PIK3CA—prostate cancer	8.31e-05	0.000348	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—ITPR1—prostate cancer	8.23e-05	0.000345	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PRKCQ—prostate cancer	8.22e-05	0.000344	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CXCL12—prostate cancer	8.18e-05	0.000343	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	8.09e-05	0.000339	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LPAR1—prostate cancer	8.08e-05	0.000339	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GRP—prostate cancer	8.08e-05	0.000339	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PLCB2—prostate cancer	8e-05	0.000335	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LRP2—prostate cancer	8e-05	0.000335	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NRP1—prostate cancer	7.97e-05	0.000334	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—ADRB2—prostate cancer	7.9e-05	0.000331	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CX3CL1—prostate cancer	7.85e-05	0.000329	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—P4HB—prostate cancer	7.85e-05	0.000329	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—ADRB2—prostate cancer	7.73e-05	0.000324	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—VAV3—prostate cancer	7.7e-05	0.000323	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HIST1H2BG—prostate cancer	7.7e-05	0.000323	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GRB7—prostate cancer	7.63e-05	0.00032	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDE4D—prostate cancer	7.63e-05	0.00032	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—VAV3—prostate cancer	7.54e-05	0.000316	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—ITPR1—prostate cancer	7.47e-05	0.000313	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PRKCQ—prostate cancer	7.46e-05	0.000313	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HIST1H4H—prostate cancer	7.44e-05	0.000312	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—CXCL8—prostate cancer	7.44e-05	0.000312	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	7.43e-05	0.000311	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VIP—prostate cancer	7.41e-05	0.000311	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GNRH1—prostate cancer	7.41e-05	0.000311	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	7.41e-05	0.00031	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—ITPR1—prostate cancer	7.31e-05	0.000306	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GNG5—prostate cancer	7.26e-05	0.000304	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GRP—prostate cancer	7.18e-05	0.000301	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LPAR1—prostate cancer	7.18e-05	0.000301	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PLCB2—prostate cancer	7.11e-05	0.000298	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LRP2—prostate cancer	7.11e-05	0.000298	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ADRB2—prostate cancer	7.02e-05	0.000294	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CX3CL1—prostate cancer	6.97e-05	0.000292	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—P4HB—prostate cancer	6.97e-05	0.000292	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—VAV3—prostate cancer	6.84e-05	0.000287	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HIST1H2BG—prostate cancer	6.84e-05	0.000287	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GRB7—prostate cancer	6.78e-05	0.000284	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDE4D—prostate cancer	6.78e-05	0.000284	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ITPR1—prostate cancer	6.64e-05	0.000278	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HIST1H4H—prostate cancer	6.61e-05	0.000277	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—CXCL8—prostate cancer	6.6e-05	0.000277	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	6.58e-05	0.000276	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GNG5—prostate cancer	6.45e-05	0.00027	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTHLH—prostate cancer	6.33e-05	0.000265	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TGFBR1—prostate cancer	6.33e-05	0.000265	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKR1C3—prostate cancer	6.22e-05	0.000261	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PRKACB—prostate cancer	6.19e-05	0.000259	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—THBS1—prostate cancer	6.03e-05	0.000253	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PPP3CA—prostate cancer	6.03e-05	0.000253	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ANXA1—prostate cancer	5.95e-05	0.000249	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PRKCZ—prostate cancer	5.84e-05	0.000245	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CG—prostate cancer	5.71e-05	0.000239	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PARP1—prostate cancer	5.64e-05	0.000236	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGFR4—prostate cancer	5.64e-05	0.000236	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTHLH—prostate cancer	5.62e-05	0.000235	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TGFBR1—prostate cancer	5.62e-05	0.000235	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CALCA—prostate cancer	5.57e-05	0.000233	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKR1C3—prostate cancer	5.53e-05	0.000232	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PRKACB—prostate cancer	5.5e-05	0.00023	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCL12—prostate cancer	5.44e-05	0.000228	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PPP3CA—prostate cancer	5.36e-05	0.000225	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—THBS1—prostate cancer	5.36e-05	0.000225	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ANXA1—prostate cancer	5.28e-05	0.000221	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PRKCZ—prostate cancer	5.19e-05	0.000217	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CG—prostate cancer	5.18e-05	0.000217	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CASP9—prostate cancer	5.12e-05	0.000215	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CG—prostate cancer	5.07e-05	0.000212	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CD—prostate cancer	5.02e-05	0.00021	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGFR4—prostate cancer	5.01e-05	0.00021	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PARP1—prostate cancer	5.01e-05	0.00021	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PRKCQ—prostate cancer	4.96e-05	0.000208	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NGFR—prostate cancer	4.96e-05	0.000208	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CALCA—prostate cancer	4.95e-05	0.000207	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAP3K7—prostate cancer	4.9e-05	0.000206	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCL12—prostate cancer	4.83e-05	0.000202	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGF10—prostate cancer	4.72e-05	0.000198	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ADRB2—prostate cancer	4.67e-05	0.000196	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—JAK2—prostate cancer	4.6e-05	0.000193	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CG—prostate cancer	4.6e-05	0.000193	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—MAP2K1—prostate cancer	4.59e-05	0.000192	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CD—prostate cancer	4.56e-05	0.000191	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VAV3—prostate cancer	4.55e-05	0.000191	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CASP9—prostate cancer	4.55e-05	0.000191	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TGFBR2—prostate cancer	4.49e-05	0.000188	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CD—prostate cancer	4.46e-05	0.000187	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ITPR1—prostate cancer	4.41e-05	0.000185	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PRKCQ—prostate cancer	4.41e-05	0.000185	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NGFR—prostate cancer	4.41e-05	0.000185	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CB—prostate cancer	4.37e-05	0.000183	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAP3K7—prostate cancer	4.36e-05	0.000183	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IGF1R—prostate cancer	4.22e-05	0.000177	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—CXCL8—prostate cancer	4.2e-05	0.000176	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF10—prostate cancer	4.19e-05	0.000176	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—JAK2—prostate cancer	4.18e-05	0.000175	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ADRB2—prostate cancer	4.15e-05	0.000174	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—JAK2—prostate cancer	4.09e-05	0.000171	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MAP2K1—prostate cancer	4.07e-05	0.000171	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LPL—prostate cancer	4.05e-05	0.00017	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CD—prostate cancer	4.05e-05	0.00017	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VAV3—prostate cancer	4.04e-05	0.000169	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—IL2—prostate cancer	4.02e-05	0.000168	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDGFRB—prostate cancer	4.01e-05	0.000168	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TGFBR2—prostate cancer	3.98e-05	0.000167	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CB—prostate cancer	3.97e-05	0.000166	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ITPR1—prostate cancer	3.92e-05	0.000164	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ITGB3—prostate cancer	3.91e-05	0.000164	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CB—prostate cancer	3.88e-05	0.000163	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CXCL8—prostate cancer	3.82e-05	0.00016	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ERBB3—prostate cancer	3.79e-05	0.000159	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGFR2—prostate cancer	3.78e-05	0.000159	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IGF1R—prostate cancer	3.75e-05	0.000157	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CXCL8—prostate cancer	3.73e-05	0.000156	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—JAK2—prostate cancer	3.71e-05	0.000156	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL2—prostate cancer	3.65e-05	0.000153	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TERT—prostate cancer	3.63e-05	0.000152	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LPL—prostate cancer	3.59e-05	0.000151	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—IL2—prostate cancer	3.57e-05	0.000149	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDGFRB—prostate cancer	3.56e-05	0.000149	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CB—prostate cancer	3.53e-05	0.000148	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HIF1A—prostate cancer	3.47e-05	0.000146	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ITGB3—prostate cancer	3.47e-05	0.000145	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LEP—prostate cancer	3.39e-05	0.000142	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CXCL8—prostate cancer	3.39e-05	0.000142	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ERBB3—prostate cancer	3.37e-05	0.000141	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGFR2—prostate cancer	3.36e-05	0.000141	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CAV1—prostate cancer	3.36e-05	0.000141	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KDR—prostate cancer	3.32e-05	0.000139	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL2—prostate cancer	3.24e-05	0.000136	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ESR1—prostate cancer	3.24e-05	0.000136	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TERT—prostate cancer	3.23e-05	0.000135	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—BAD—prostate cancer	3.16e-05	0.000132	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HIF1A—prostate cancer	3.09e-05	0.000129	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CG—prostate cancer	3.06e-05	0.000128	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—APC—prostate cancer	3.06e-05	0.000128	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IRS1—prostate cancer	3.03e-05	0.000127	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EGF—prostate cancer	3.03e-05	0.000127	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LEP—prostate cancer	3.01e-05	0.000126	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CAV1—prostate cancer	2.99e-05	0.000125	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KDR—prostate cancer	2.95e-05	0.000124	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GSK3B—prostate cancer	2.94e-05	0.000123	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—INS—prostate cancer	2.9e-05	0.000121	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ESR1—prostate cancer	2.88e-05	0.000121	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CREBBP—prostate cancer	2.84e-05	0.000119	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—BAD—prostate cancer	2.81e-05	0.000118	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IGF1—prostate cancer	2.8e-05	0.000117	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—EGFR—prostate cancer	2.79e-05	0.000117	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CG—prostate cancer	2.72e-05	0.000114	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—APC—prostate cancer	2.72e-05	0.000114	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAP2K1—prostate cancer	2.71e-05	0.000114	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CD—prostate cancer	2.69e-05	0.000113	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EGF—prostate cancer	2.69e-05	0.000113	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IRS1—prostate cancer	2.69e-05	0.000113	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CA—prostate cancer	2.67e-05	0.000112	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SERPINE1—prostate cancer	2.66e-05	0.000112	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—KRAS—prostate cancer	2.63e-05	0.00011	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GSK3B—prostate cancer	2.61e-05	0.000109	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGF2—prostate cancer	2.58e-05	0.000108	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—INS—prostate cancer	2.57e-05	0.000108	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NOS3—prostate cancer	2.54e-05	0.000106	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CREBBP—prostate cancer	2.52e-05	0.000106	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IGF1—prostate cancer	2.49e-05	0.000104	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—EGFR—prostate cancer	2.48e-05	0.000104	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—JAK2—prostate cancer	2.47e-05	0.000103	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CA—prostate cancer	2.42e-05	0.000101	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MDM2—prostate cancer	2.41e-05	0.000101	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAP2K1—prostate cancer	2.41e-05	0.000101	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CD—prostate cancer	2.39e-05	0.0001	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ERBB2—prostate cancer	2.38e-05	9.96e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CA—prostate cancer	2.37e-05	9.92e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SERPINE1—prostate cancer	2.36e-05	9.91e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CB—prostate cancer	2.35e-05	9.83e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—KRAS—prostate cancer	2.34e-05	9.81e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF2—prostate cancer	2.29e-05	9.59e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NOS3—prostate cancer	2.26e-05	9.46e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCL8—prostate cancer	2.25e-05	9.44e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CDKN1B—prostate cancer	2.2e-05	9.22e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—JAK2—prostate cancer	2.19e-05	9.19e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—AKT1—prostate cancer	2.18e-05	9.12e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CASP3—prostate cancer	2.16e-05	9.04e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL2—prostate cancer	2.15e-05	9.03e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	2.15e-05	9.01e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL6—prostate cancer	2.14e-05	8.98e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MDM2—prostate cancer	2.14e-05	8.97e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	2.11e-05	8.85e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCND1—prostate cancer	2.1e-05	8.8e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	2.08e-05	8.73e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CTNNB1—prostate cancer	2.08e-05	8.71e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MMP9—prostate cancer	2.04e-05	8.54e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CDKN1A—prostate cancer	2.03e-05	8.51e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTEN—prostate cancer	2.03e-05	8.49e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	2e-05	8.39e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	1.98e-05	8.29e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	1.96e-05	8.19e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	1.93e-05	8.1e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EP300—prostate cancer	1.93e-05	8.1e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CASP3—prostate cancer	1.92e-05	8.03e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL2—prostate cancer	1.91e-05	8.02e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL6—prostate cancer	1.9e-05	7.98e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SRC—prostate cancer	1.88e-05	7.88e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCND1—prostate cancer	1.87e-05	7.82e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	1.85e-05	7.74e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	1.83e-05	7.67e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—STAT3—prostate cancer	1.81e-05	7.6e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.81e-05	7.59e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.8e-05	7.56e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.8e-05	7.54e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.76e-05	7.36e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.72e-05	7.19e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MYC—prostate cancer	1.68e-05	7.06e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	1.68e-05	7.04e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.67e-05	7e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EGFR—prostate cancer	1.65e-05	6.9e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.63e-05	6.81e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.61e-05	6.75e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KRAS—prostate cancer	1.56e-05	6.52e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.5e-05	6.27e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.49e-05	6.25e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	1.46e-05	6.13e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	1.43e-05	5.99e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TP53—prostate cancer	1.38e-05	5.8e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	1.38e-05	5.79e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	1.27e-05	5.32e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL6—prostate cancer	1.27e-05	5.31e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TP53—prostate cancer	1.23e-05	5.15e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKT1—prostate cancer	1.17e-05	4.89e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL6—prostate cancer	1.12e-05	4.71e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	1.04e-05	4.35e-05	CbGpPWpGaD
